about
Prophylactic lidocaine for myocardial infarctionProphylactic lidocaine for myocardial infarctionEpidemiology of coronary heart disease and acute coronary syndromeSecular trends in acute coronary syndrome hospitalization from 1994 to 2005.An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United NationsEpidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences.Ly6C(low) and not Ly6C(high) macrophages accumulate first in the heart in a model of murine pressure-overload.Classically and alternatively activated macrophages contribute to tissue remodelling after myocardial infarction.Multiple Risk Factors of Alcoholic and Non-Alcoholic Myocardial Infarction PatientsThrombospondin-1: a physiological regulator of nitric oxide signalingEnhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.Allopurinol reduces the risk of myocardial infarction (MI) in the elderly: a study of Medicare claims.Long-term trends in the incidence of heart failure after myocardial infarction.Coronary heart disease attributable to passive smoking: CHD Policy Model.When do the risks of repeated courses of corticosteroids exceed the risks of surgery?Celecoxib for the treatment of atherosclerosis.Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.Pre-event quality of life and its influence on the post-event quality of life among patients with ST elevation and non-ST elevation myocardial infarctions of a premier province of Sri Lanka.Increased risk of coronary heart disease in patients with hip fracture: a nationwide cohort study.High risk of cardiovascular diseases after diagnosis of multiple sclerosis.Incidence and case fatality after day 28 of first time myocardial infarction in Sweden 1987-2008.Embozene™ microspheres induced nonreperfused myocardial infarction in an experimental swine model.Effects of pre- and postconditioning on arrhythmogenesis in the in vivo rat model.Effect of Pentoxifylline in Ameliorating Myocardial Injury in Patients With Myocardial Infarction Undergoing Thrombolytic Therapy: A Pilot Randomized Clinical Trial.A randomized study of prourokinase during primary percutaneous coronary intervention in acute ST-segment elevation myocardial infarction.Is having asthma associated with an increased risk of dying from cardiovascular disease? A prospective cohort study of 446 346 Taiwanese adults.Gout and the risk of myocardial infarction in older adults: a study of Medicare recipients.Prediction of dyslipidemia using gene mutations, family history of diseases and anthropometric indicators in children and adolescents: The CASPIAN-III study.Cholinergic stimulation with pyridostigmine protects myocardial infarcted rats against ischemic-induced arrhythmias and preserves connexin43 proteinSoluble CD74 Reroutes MIF/CXCR4/AKT-Mediated Survival of Cardiac Myofibroblasts to Necroptosis
P2860
Q24187816-45ABDE7A-D401-4F70-9E60-B16819F55FAEQ24235110-EB332CE8-75AE-475A-8715-03A65992D4B0Q26738525-3DA2716D-1810-47E7-B585-79F17158B23CQ33776384-3B12180C-86F9-41E9-973F-A9D68EA79253Q34093032-452AE662-A76F-4CD3-8C12-6A542AC6826EQ34315976-168C5BC4-666D-4EE2-9F72-68434D83187BQ34362848-E45F72C3-F723-468E-A12C-0288A3146C1DQ34557178-37FA6232-D4FD-4AE9-8F56-4B3E0B6AFB52Q35893327-488275F4-61BD-4895-A72D-0B7D15FD65CFQ36718465-1F73CFA9-BB9C-4C55-8409-006577C5C4D0Q36926096-8B4D4BCD-AA2E-4B17-93D2-EA0E25E7C947Q36955405-2244BDA3-0226-4704-8AD5-697E4BD0C46AQ37274458-7B647D3B-A60D-494B-8834-96C2355E2FA5Q37312662-46C39D18-9CF5-4A2B-837F-B473ADD6F6CEQ37614187-8B56847E-C231-4F60-A20C-ED0A03086FCCQ38242037-96FC7B3F-2E28-4B0D-B8DB-169C47712ACCQ38759585-79A00BD6-1277-4FE8-AB5C-FC117C6AC3DAQ38853391-7C58B361-0369-4098-9D6E-B5098CA83E12Q39204160-6251BA66-CCB6-45EB-985F-DB33E5C8562DQ41174809-18928119-5265-4714-9D7A-ECAF0B17B47AQ43549937-2A427821-7D4F-4E6A-A2D7-B12D3D6E33DAQ43920881-2A1DF377-DB6E-45AD-A055-8B0966BC8F9AQ45082424-A4D6BEB0-5818-4959-85DB-93FCEA30C53BQ45205640-644D0294-7AB6-47FB-B021-EBFDC6898224Q48132348-19AC08EE-43E4-4A44-9C26-7C2DCDD34DA9Q48243073-044DA799-41E9-4236-9D6F-8B68057A5417Q55007483-55B9BEF6-4F8C-4E04-A25E-D84FA7E4ADCBQ55332127-7BF06900-459E-4882-A322-20F6B0589511Q55716534-4954923C-6654-4358-B9DE-4638C2B3211EQ57843310-8A6B1223-E542-423D-9AC5-360F6FA9ED19Q58127453-71292E32-F1BF-427E-B51F-F2BA0E50C0A3
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Epidemiology of myocardial infarction.
@en
type
label
Epidemiology of myocardial infarction.
@en
prefLabel
Epidemiology of myocardial infarction.
@en
P2860
P1476
Epidemiology of myocardial infarction.
@en
P2093
Véronique L Roger
P2860
P304
537-52; ix
P356
10.1016/J.MCNA.2007.03.007
P577
2007-07-01T00:00:00Z